LeadStory

CNBC

Trump signs new pharma executive order

CNBC · Older
CNBC
CNBC
Older

President Trump has signed an executive order aimed at boosting the U.S. pharma supply chain. Peter Navarro, White House senior counselor for trade and manufacturing, discusses its effects.

Breakdown
  • President Trump signed an executive order to strengthen the U.S. pharma supply chain.
  • The order establishes a reserve of active pharmaceutical ingredients (APIs) and a list of critical drugs. 4s
  • Government agencies will issue long-term contracts to support domestic drug manufacturing. 52s
  • The order aims to reduce U.S. reliance on pharmaceutical imports from China and India. 1m 52s
  • Potential pharmaceutical tariffs are anticipated following a Department of Commerce review. 2m 29s
Politics